Aansh Ivf Hospital Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -7.52%
- Profit Growth -15.20%
- Ebitda 4.00%
- Net Worth -9.46%
- Total Assets 17.36%
About Aansh Ivf Hospital
Aansh Ivf Hospital Private Limited (AIHPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 12 November 2018 (Six years and two months 21 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Corporate was formerly known as Maa Ivf Hospital Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Santosh Gaur, Shilendra Gaur, and Chikkarangaiah Bangalore serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999KA2018PTC118411
- Company No.
118411
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Nov 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Aansh Ivf Hospital?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Gaur  | Director | 12-Nov-2018 | Current |
| Shilendra Gaur | Director | 12-Nov-2018 | Current |
| Chikkarangaiah Bangalore | Director | 14-Jan-2019 | Current |
Financial Performance of Aansh Ivf Hospital.
Aansh Ivf Hospital Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.52% decrease. The company also saw a substantial fall in profitability, with a 15.2% decrease in profit. The company's net worth dipped by a decrease of 9.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aansh Ivf Hospital?
In 2023, Aansh Ivf Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aansh Ivf Hospital?
Aansh Ivf Hospital has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aansh Ivf Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aansh Ivf Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.